Short Summary
Apple Inc. successfully secured the institution of Inter Partes Review against Apex Beam Technologies LLC's patent, challenging 17 claims based on obviousness over prior art including Yeo and TS36.
Detailed Summary
The Patent Trial and Appeal Board granted institution of IPR2025-00905, allowing Apple Inc. to challenge U.S. Patent No. 11,917,581 B2. The decision was based on the finding that Petitioner demonstrated a reasonable likelihood of prevailing regarding Claim 1's unpatentability over prior art references Yeo and TS36. Although the Board noted that the remaining obviousness challenges would be reserved for trial, all 17 challenged claims were instituted.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Apple Inc. vs Apex Beam Technologies LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Perplexity AI, Inc.vsComet ML, Inc.
Perplexity AI and Comet ML reached a settlement covering all disputes over U.S. Patent 11,650,968, prompting the PTAB to terminate the IPR before instituting trial and to keep the settlement agreement confidential.
Cambridge Mobile Telematics, Inc.vsSfara, Inc.
The PTAB denied institution of IPR for Cambridge Mobile Telematics against Sfara, citing Petitioner's failure to provide a proper claim construction under 37 C.F.R. § 42.104(b)(3). Additionally, the Board found that key 'component' terms functioned as means-plus-function limitations lacking cognizable structure in the patent specification.
Ford Motor CompanyvsAutoConnect Holdings LLC
Ford Motor Company filed a response urging the PTAB Director to deny AutoConnect Holdings’ request for review of a prior discretionary denial. Ford relies on long‑standing settled expectations from its relationship with Flextronics and AutoConnect’s lapse of maintenance fees to argue the request should be denied.
Geotab Inc. et al.vsFractus, S.A.
Geotab has petitioned the PTAB to invalidate all twenty claims of Fractus’s ’200 antenna patent, citing obviousness over Dou and Jing and lack of written description for 4G‑related features. The petition seeks institution of the IPR and cancellation of the claims.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Halozyme seeks Director Review to overturn the PTAB’s institution of a post‑grant review of its ’035 enzyme patent. The petition contends the Board mis‑interpreted claim language and mis‑applied eligibility standards, and argues that Fintiv factors demand denial of institution.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.